X-37 Overview
- Year Founded
-
2018

- Status
-
Private
- Employees
-
2

- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$14.5M
- Investors
-
4
X-37 General Information
Description
Developer of a drug development platform designed to facilitate the discovery of various medicines for patients. The company's platform uses artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against high-value pharmaceutical targets, enabling the healthcare sector to discover and develop medicines faster.
Contact Information
Website
x37.aiCorporate Office
- 400 Oyster Point Boulevard
- Suite 202
- South San Francisco, CA 94080
- United States
Corporate Office
- 400 Oyster Point Boulevard
- Suite 202
- South San Francisco, CA 94080
- United States
X-37 Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Early Stage VC (Series A) | 14-Nov-2019 | $14.5M | Completed | Pre-Clinical Trials | ||
1. Seed Round | 01-Dec-2018 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
X-37 Comparisons
Industry
Financing
Details
X-37 Competitors (49)
One of X-37’s 49 competitors is Deep Genomics, a Venture Capital-Backed company based in Toronto, Canada.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Deep Genomics | Venture Capital-Backed | Toronto, Canada | ||||
Sphere Fluidics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
Valo | Venture Capital-Backed | Lexington, MA | ||||
BioBlocks | Corporate Backed or Acquired | Hamilton, NJ | ||||
insitro | Venture Capital-Backed | South San Francisco, CA |
X-37 Signals
X-37 Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Alpha Intelligence Capital | Venture Capital | Minority | ||
BlackPine Group | Venture Capital | Minority | ||
Hemi Ventures | Venture Capital | Minority | ||
DCVC Bio | Venture Capital | Minority |
X-37 FAQs
-
When was X-37 founded?
X-37 was founded in 2018.
-
Where is X-37 headquartered?
X-37 is headquartered in South San Francisco, CA.
-
What is the size of X-37?
X-37 has 2 total employees.
-
What industry is X-37 in?
X-37’s primary industry is Drug Discovery.
-
Is X-37 a private or public company?
X-37 is a Private company.
-
What is X-37’s current revenue?
The current revenue for X-37 is
. -
How much funding has X-37 raised over time?
X-37 has raised $14.5M.
-
Who are X-37’s investors?
Alpha Intelligence Capital, BlackPine Group, Hemi Ventures, and DCVC Bio have invested in X-37.
-
Who are X-37’s competitors?
Deep Genomics, Sphere Fluidics, Valo, BioBlocks, and insitro are some of the 49 competitors of X-37.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »